Who Should Not Take
GLP-1 Weight Loss Medications

Introduction

GLP-1 medications can be effective for many patients seeking medical weight loss, but they are not appropriate for everyone. Understanding who should not take these medications—and why—is an important part of making informed decisions about your health.

Your clinician will review your complete medical history to determine if GLP-1 medications are safe and appropriate for you. This article provides an overview of the key contraindications and cautions.

This information is educational only and does not replace an individualized medical evaluation.

Absolute Contraindications

The following conditions are generally considered absolute contraindications, meaning GLP-1 medications should not be used:

Personal or Family History of Medullary Thyroid Carcinoma (MTC)

GLP-1 medications carry a boxed warning about thyroid tumors. In animal studies, these medications were associated with thyroid C-cell tumors. While this hasn't been proven in humans, patients with a personal or family history of MTC should not take these medications.

Multiple Endocrine Neoplasia Syndrome Type 2 (MEN 2)

MEN 2 is a genetic condition that increases the risk of thyroid cancer and other endocrine tumors. Patients with MEN 2 should not use GLP-1 medications.

Known Hypersensitivity or Allergic Reaction

If you've had a serious allergic reaction to semaglutide, tirzepatide, or any component of these medications, they should not be used again.

Pregnancy and Breastfeeding

GLP-1 medications are not approved for use during pregnancy or breastfeeding.

Pregnancy

These medications should be discontinued at least 2 months before a planned pregnancy. If you become pregnant while taking a GLP-1 medication, stop the medication and contact your healthcare provider immediately.

Breastfeeding

It's not known whether GLP-1 medications pass into breast milk. Because of potential risks to infants, breastfeeding is generally not recommended while taking these medications.

Conditions Requiring Careful Consideration

The following conditions don't necessarily prevent use, but require careful evaluation and may influence whether GLP-1 medications are appropriate:

History of Pancreatitis

GLP-1 medications have been associated with pancreatitis in some patients. Those with a history of pancreatitis may be at higher risk, and the decision to use these medications requires careful benefit-risk analysis.

Gallbladder Disease

Rapid weight loss can increase the risk of gallstones. Patients with existing gallbladder problems may need additional monitoring.

Diabetic Retinopathy

In patients with diabetes and existing retinopathy, rapid improvement in blood sugar control may temporarily worsen retinopathy. Additional monitoring may be needed.

Severe Gastrointestinal Disease

Conditions like gastroparesis (delayed stomach emptying), severe GERD, or inflammatory bowel disease may be worsened by GLP-1 medications, which slow gastric emptying.

History of Eating Disorders

Weight loss medications require careful consideration in patients with a history of eating disorders. These medications affect appetite and eating behavior in significant ways.

Severe Kidney Disease

While GLP-1 medications don't require dose adjustment for most patients with kidney disease, severe kidney impairment may increase the risk of side effects, particularly if dehydration occurs from GI symptoms.

Medication Interactions

GLP-1 medications may interact with other medications, including:

• Insulin and sulfonylureas: Increased risk of hypoglycemia; doses may need adjustment
• Oral medications: Slowed gastric emptying may affect absorption of some oral drugs
• Warfarin: May affect INR levels; closer monitoring may be needed

Always provide your clinician with a complete list of current medications, including supplements.

Age Considerations

GLP-1 medications for weight loss are FDA-approved for adults. Use in adolescents may be considered in specific circumstances under specialist care. Safety and efficacy in children under 12 have not been established.

For older adults, considerations include overall health status, other medications, and ability to maintain adequate nutrition.

The Importance of Clinical Evaluation

This article provides general information, but only a licensed clinician can determine whether GLP-1 medications are appropriate for your specific situation. During your consultation, expect a thorough review of:

• Your complete medical history
• Current medications and supplements
• Family medical history
• Previous weight loss attempts
• Current symptoms and health concerns

Key Takeaways

• Personal or family history of medullary thyroid carcinoma or MEN 2 are absolute contraindications
• GLP-1 medications should not be used during pregnancy or breastfeeding
• History of pancreatitis, gallbladder disease, or severe GI conditions require careful evaluation
• Many medication interactions are possible and must be reviewed
• A thorough clinical evaluation is essential before starting treatment